We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Japanese Orthopedic Device Sector Influenced by Cultural Factors

By HospiMedica International staff writers
Posted on 19 May 2014
The Japanese orthopedic device market is uniquely influenced by cultural preferences that make the market distinct from other major markets. These are the findings of Decision Resources Group (DRG; Burlington, MA, USA), which provides information and insights on critical issues within the healthcare industry.

For example, Japanese patients have a cultural aversion to surgery because it is seen as too invasive. As a result, most patients will defer large-joint surgery, such as knee replacements for as long as possible or until it is absolutely necessary, such as in the case of a hip fracture. But since certain practices, such as sitting on the floor to eat, are important culturally, when Japanese patients do opt for surgical procedures they will often choose more expensive options such as mobile-bearing knee implants, which offer greater flexion.

Japanese doctors are also generally reluctant adopters of new minimally invasive surgery (MIS) technologies such as unicondylar knee implants or intramedullary nails. Spinal procedures are also rarely performed using the highly invasive anterior approach. These factors somewhat limit the volume of invasive orthopedic procedures performed in Japan, and will continue to do so through 2022. However, rising demand for orthopedic procedures that fall in line with an aging population and increasing clinical data will result in gradual market expansion as interest in these technologies gradually picks up.

An additional hurdle is that the Japanese regulatory system is currently in a reshaping phase, which is also unlikely to change soon, and companies will continue to have to deal with an extremely cumbersome approval process. This is shown by the fact that no new spinal non-fusion technologies are anticipated to enter this market by 2022, despite significant product development activity in other countries. Additionally, biennial reimbursement cuts set by the Japanese Ministry of Health, Labor & Welfare (MHLW) will continue to limit the orthopedic device market.

“Local manufacturers have an advantage in Japan because they are better able to navigate local laws and customs,” said DRG analyst Rene Azeez. “As a result, many multinational competitors are working with Japanese distributors and are setting up local offices to establish networks with facilities and physicians in the area.”

Related Links:

Decision Resources Group



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
X-ray Diagnostic System
FDX Visionary-A
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex